- Home
- Publications
- Publication Search
- Publication Details
Title
Current Challenges for IDO2 as Target in Cancer Immunotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-22
DOI
10.3389/fimmu.2021.679953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
- (2020) Panagiotis Sarantis et al. World Journal of Gastrointestinal Oncology
- Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
- (2020) Martina Mandarano et al. Frontiers in Immunology
- Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
- (2020) Kento Fujii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
- (2020) Lijie Zhai et al. Frontiers in Immunology
- Viral pseudoenzymes in infection and immunity
- (2020) Ting‐Yu Wang et al. FEBS Journal
- Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
- (2019) Valerio Napolioni et al. Frontiers in Immunology
- Indoleamine 2,3‐dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma
- (2019) Wakana Yamasuge et al. CANCER SCIENCE
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Emerging concepts in pseudoenzyme classification, evolution, and signaling
- (2019) António J. M. Ribeiro et al. Science Signaling
- Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors
- (2018) Anthony R. Guastella et al. JOURNAL OF NEURO-ONCOLOGY
- Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling
- (2018) Yasuko Yamamoto et al. Scientific Reports
- Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase
- (2018) Maria Winters et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1
- (2016) Elisa Albini et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- IDO2 Modulates T Cell–Dependent Autoimmune Responses through a B Cell–Intrinsic Mechanism
- (2016) Lauren M. F. Merlo et al. JOURNAL OF IMMUNOLOGY
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth
- (2016) Yanling Liu et al. Oncotarget
- Amino acid auxotrophy as a system of immunological control nodes
- (2015) Peter J Murray NATURE IMMUNOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
- (2015) Nicolas van Baren et al. Frontiers in Immunology
- Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1
- (2014) Georgios Pantouris et al. AMINO ACIDS
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis
- (2014) L. M. F. Merlo et al. JOURNAL OF IMMUNOLOGY
- Aryl hydrocarbon receptor control of a disease tolerance defence pathway
- (2014) Alban Bessede et al. NATURE
- IDO2 in Immunomodulation and Autoimmune Disease
- (2014) George C. Prendergast et al. Frontiers in Immunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
- (2011) Maria T Pallotta et al. NATURE IMMUNOLOGY
- Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2
- (2010) Christopher Jonathan Daraius Austin et al. AMINO ACIDS
- Control of immune response by amino acid metabolism
- (2010) Ursula Grohmann et al. IMMUNOLOGICAL REVIEWS
- An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
- (2010) J. D. Mezrich et al. JOURNAL OF IMMUNOLOGY
- Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism
- (2010) N. T. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
- (2009) Agnieszka K. Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search